Your browser doesn't support javascript.
loading
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
Block, Geoffrey A; Fishbane, Steven; Rodriguez, Mariano; Smits, Gerard; Shemesh, Shay; Pergola, Pablo E; Wolf, Myles; Chertow, Glenn M.
Afiliação
  • Block GA; Denver Nephrologists PC, Denver, CO. Electronic address: gablock@dnresearch.org.
  • Fishbane S; Hofstra-North Shore LIJ School of Medicine, Great Neck, NY.
  • Rodriguez M; Nephrology Service, IMIBIC, Hospital Universitario, Cordoba, Spain.
  • Smits G; Denver Nephrologists PC, Denver, CO.
  • Shemesh S; Keryx Biopharmaceuticals Inc, New York, NY.
  • Pergola PE; Renal Associates PA, San Antonio, TX.
  • Wolf M; Department of Medicine, Institute for Public Health and Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL.
  • Chertow GM; Stanford University School of Medicine, Palo Alto, CA.
Am J Kidney Dis ; 65(5): 728-36, 2015 May.
Article em En | MEDLINE | ID: mdl-25468387

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatos / Compostos Férricos / Anemia Ferropriva / Insuficiência Renal Crônica / Hematínicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Kidney Dis Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatos / Compostos Férricos / Anemia Ferropriva / Insuficiência Renal Crônica / Hematínicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Kidney Dis Ano de publicação: 2015 Tipo de documento: Article